| Literature DB >> 36051487 |
Sirine Ben Slima1, Naourez Ktari2,3, Aicha Chouikhi1, Amina Hzami1, Sana Bardaa4, Imen Trabelsi1, Basma Ben Salah5, Riadh Ben Salah1.
Abstract
The present study undertakes the extraction of a novel polysaccharide from Lepidium sativum (PLS) and the determination of its physicochemical composition and antioxidant properties, as well as its potential wound healing activity in alloxan-induced diabetic rats. This polysaccharide presented a lighter natural color, whose luminosity (L∗), red-green intensity (a∗), and blue-yellow intensity (b∗) were recorded at 63.26, 5.87, and 27.28, respectively. The PLS was structurally characterized by Fourier transform infrared (FT-IR) spectroscopy, UV spectrum, high performance liquid chromatography (HPLC), gas chromatography (GC), nuclear resonance magnetic (NMR), and high-pressure gel filtration chromatography. The FT-IR and UV spectra showed the characteristic band of polysaccharides. According to HPLC, the crude PLS is a heteropolysaccharide composed of glucose, xylose, and galactose. Results obtained by 1H NMR indicated that PLS consisted of three monosaccharide residues with α and β anomers. This novel polysaccharide had an average molecular weight of 98.51 kDa and displayed potential antioxidant activities determined through three different assays: scavenging activity against 2,2'-azino-bis-3-ethylbenzothiazoline-6-sulphonic acid (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging assay, and reducing power. These results strongly support the beneficial effects of the PLS to accelerate wound healing in diabetic rats. Indeed, its application significantly increased wound contraction percentage (98 ± 1.11%) after 14 days of experiment. Furthermore, the histological assessment of the PLS-treated group demonstrated complete reepithelialized wounds by accelerating collagen synthesis. In general, the findings affirmed that PLS is efficient on wound closure in alloxan-induced diabetic rats.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36051487 PMCID: PMC9427275 DOI: 10.1155/2022/7858865
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.246
Physicochemical properties of PLS.
| Parameters | PLS |
|---|---|
| Yield (%) | 8.2 ± 0.99 |
| Moisture (%) | 4.33 ± 0.10 |
| Ash (%) | 5.99 ± 0.65 |
| Proteins (%) | 1.23 ± 0.14 |
| Fat (%) | 0.03 ± 0.01 |
| Polysaccharides (%) | 88.58 ± 0.06 |
| Color | |
|
| 5.87 ± 0.01 |
|
| 27.28 ± 0.02 |
|
| 63.26 ± 0.01 |
Figure 1Scan of PLS within the wavelength range of 200-800 nm.
Figure 2FT-IR spectra of PLS.
Figure 31H NMR spectra of PLS.
Figure 4Gel filtration chromatographs of PLS.
Figure 5HPLC analysis of PLS (a). HPLC analysis of glucose (b). HPLC analysis of galactose (c). HPLC analysis of xylose (d).
Figure 6GC of PLS.
Figure 7Antioxidants activities: (a) DPPH radical scavenging activity, (b) ABTS scavenging activity, and (c) reducing power determination.
Figure 8(a) Injury wounds taken for the different groups on days 1, 3, 5, 10, 12, and 14. Group I: control diabetic group treated with a saline solution; group II: diabetic group treated with glycerol; group III: positive group in which animals were treated with Cytol Centella cream; and group IV: diabetic group treated with PLS hydrogel. (b) Percentage of wound contraction for different groups. Group I: control diabetic group treated with a saline solution; group II: diabetic group treated with glycerol; group III: positive group in which animals were treated with Cytol Centella cream; and group IV: diabetic group treated with PLS hydrogel. Different letters represent significant difference at p < 0.05.
Figure 9Photomicrographs of skin sections coloured with hematoxylin-eosin after 14 days of injury induction. Group I : rats treated with a saline solution; group II: diabetic rats treated with glycerol; group III: positive group in which rats were treated with Cytol Centella cream; and group IV: diabetic rats treated with PLS hydrogel. E: epidermis; D: dermis. Three independent experiments on three animals per group were used.
Hydroxyproline content in the tissue of the different experimental animal groups.
| Groups | Hydroxyproline amounts (mg/g of tissue) |
|---|---|
| Group I | 13.02 ± 2.02a |
| Group II | 13.89 ± 3.05a |
| Group III | 20.54 ± 2.11b |
| Group IV | 21.99 ± 2.99b |
Group I: control diabetic group treated with a saline solution; group II: diabetic group treated with glycerol; group III: positive group in which animals were treated with Cytol Centella cream; and group IV: diabetic group treated with PLS hydrogel. Values are given as mean ± SD. Data with different letters for each column represent significant difference at p < 0.05.